Tumors and their microenvironments: tilling the soil. Commentary re: A. M. Scott et al., A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin. Cancer Res., 9: 1639-1647, 2003. [electronic resource]
Producer: 20040112Description: 1590-5 p. digitalISSN:- 1078-0432
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antigens, Neoplasm -- metabolism
- Biomarkers, Tumor -- metabolism
- Clinical Trials, Phase I as Topic
- Colonic Neoplasms -- drug therapy
- Endopeptidases
- Gelatinases
- Humans
- Lung Neoplasms -- drug therapy
- Membrane Proteins
- Serine Endopeptidases -- metabolism
No physical items for this record
Publication Type: Journal Article; Comment
There are no comments on this title.
Log in to your account to post a comment.